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Abstract
Long non-coding RNAs (lncRNAs) regulate critical cellular processes and their dysregulation 
contributes to multiple diseases. Although only a few lncRNAs have defined mechanisms, many of 
these characterized lncRNAs interact with transcription factors to regulate gene expression, 
suggesting a common mechanism of action. Identifying RNA-bound transcription factors is 
especially challenging due to inefficient RNA immunoprecipitation and low abundance of many 
transcription factors. Here we describe a highly sensitive, user-friendly, and inexpensive technique 
called RATA (RNA-associated transcription factor array), which utilizes a MS2-aptamer pulldown 
strategy coupled with transcription factor activation arrays for identification of transcription 
factors associated with a nuclear RNA of interest. RATA requires only ~5 million cells and 
standard molecular biology reagents for multiplexed identification of up to 96 transcription factors 
in 2–3 d. Thus, RATA offers significant advantages over other technologies for analysis of RNA-
transcription factor interactions.
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BACKGROUND
Dysregulation of lncRNAs has recently been linked to multiple human diseases, especially 
cancer [1]. While the exact mechanism of many lncRNAs remains unknown, it is becoming 
increasingly clear that many lncRNAs regulate gene expression through a variety of 
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mechanisms, including direct association with transcription factors to regulate transcription 
factor activity and/or sub-cellular localization [2]. Therefore, technologies that interrogate 
the fundamental biology of lncRNAs, especially interactions with transcription factors, 
could accelerate biological discovery across many disciplines.
Unbiased identification of RNA-bound transcription factors following RNA 
immunoprecipitation (RNA-IP) is challenging for several reasons: (1) RNA-IPs are 
generally inefficient, requiring large numbers of cells to generate sufficient eluate for 
downstream analysis; (2) many transcription factors are expressed at very low levels and (3) 
the standard technique for unbiased identification of associated proteins is mass 
spectrometry, which requires a minimum threshold level of protein for detection. For 
example, the recent methods of ChIRP–MS [3] and RAP–MS [4] comprehensively identify 
proteins that interact with endogenous RNAs in cells through crosslinking of protein-RNA 
interactions and precipitation of endogenous RNAs by capture of biotinylated antisense 
DNA oligos. Due to low purification efficiency, these protocols require 100–800 million 
cells for each condition tested in order to generate sufficient eluate for mass spectrometry 
analysis. Thus, these protocols are costly and labor-intensive and may prohibit many 
scientists from performing them. Alternatively, other methods increase protein detection by 
increasing RNA purification efficiency. For example, incubation of in vitro transcribed, 
biotinylated RNA with cell lysate significantly increases efficiency of RNA purification [5]. 
However, because this method bypasses normal processing of endogenous RNAs, it may 
capture non-physiological protein-RNA interactions resulting from addition of RNAs post-
lysis.
To overcome these obstacles, we developed a sensitive and unbiased technique for 
identifying RNA bound transcription factors called RATA [6]. This technique couples an 
RNA-IP with a high-throughput transcription factor activation array, enabling identification 
of up to 96 transcription factors in a single assay. Briefly, a mammalian cell line is co-
transfected with plasmids encoding a nuclear localized FLAG-tagged MS2 protein and an 
RNA of interest tagged with the MS2 RNA aptamer. Following IP of the MS2-tagged RNA 
with anti-FLAG antibody, the immunoprecipitate is gently and efficiently eluted with FLAG 
peptide, retaining the native confirmation of any associated proteins. Finally, the eluted 
immunoprecipitate is directly input into a commercially available transcription factor 
activation array. Importantly, the IP is performed in parallel using cells transfected with 
MS2-tagged RNA or the untagged RNA control, enabling identification of transcription 
factors that are enriched in the RNA precipitate compared to the control precipitate. Because 
RATA amplifies the transcription factor signature through streptavidin-horseradish 
peroxidase, the amount of transcription factor required for detection is significantly reduced. 
Indeed, RATA sensitively and reproducibly enriches transcription factors from ~5 million 
cells (1/2 of a 10 cm dish). Furthermore, RATA requires only a plate reader for analysis, 
which is widely available to many scientists. Following cell harvest, only 2 to 3 days are 
required for analysis of up to 96 transcription factors.
While multiple methods exist for RNA-IP from cells, we have developed this technique 
using the well-established MS2-based system. The bacteriophage MS2 coat protein binds 
with high affinity (Kd of 7 nM) in a sequence-specific manner to a viral RNA stem-loop 
Schmidt et al. Page 2
J Biol Methods. Author manuscript; available in PMC 2017 December 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
sequence (MS2 stem-loop) [7]. The V75E;A81G MS2 protein variant, selected for its lack of 
capsid formation in E. coli, has been widely adapted for localization and/or purification of 
tagged RNAs. In these approaches, a plasmid is generated to express the MS2 protein fused 
to a FLAG and/or GFP tag(s). The MS2 fusion expression plasmid, along with a second 
plasmid expressing an RNA engineered to contain multiple copies of the MS2 stem-loop 
structure, are transiently transfected into cultured cells. Highly-specific, in vivo binding of 
the MS2 fusion protein to the MS2-tagged RNA enables GFP-based localization or anti-
FLAG IP of the RNA of interest [8,9]. The IP conditions used in this protocol are based on 
the MS2-IP protocol developed by Gong and Maquat, with several notable modifications 
[10]. First, we have designed an exclusively nuclear version of the MS2 fusion protein, 
enabling purification of nuclear RNA-associated transcription factors. Second, the IP is 
performed in the absence of any cross-linking. Third, to ensure protein compatibility with 
downstream transcription factor activation arrays, associated proteins and RNAs are gently 
eluted from beads using FLAG peptide.
Following FLAG peptide elution, the immunoprecipitate is directly input into a transcription 
factor activation array capable of monitoring multiple transcription factors simultaneously. 
This technology relies on a series of biotin-labeled DNA probes corresponding to consensus 
sequences of target transcription factors. When cellular lysate, or RATA immunoprecipitate, 
is incubated with this mixture of labeled probes, specific transcription factor/probe 
complexes will form. These protein/DNA complexes can be separated from unbound 
proteins and probes through spin-column separation. The retained probes are then released, 
hybridized to a plate in which each well is pre-coated with DNA complementary to a 
specific probe, and detected upon addition of horseradish peroxidase-conjugated 
streptavidin. While these arrays typically quantify activation (i.e. nuclear localization or 
expression) of transcription factors before and after a particular treatment, RATA uses the 
arrays to quantity the amount of transcription factors present in a control or RNA-specific IP.
High sensitivity, low cost, fast turnaround time, and the relative ease of use of RATA will 
allow scientists from a wide-range of disciplines to study RNA-transcription factor 
interactions. Although we have used RATA to identify transcription factors bound to 
lncRNAs, this protocol is compatible with other types of coding and non-coding RNAs. This 
is especially important as transcription factors have been shown to associate with a variety of 
RNAs implicated in many cellular processes and diseases, including non-coding and viral 
RNAs [11,12]. In summary, RATA offers significant advantages over existing technologies 
and is critical for scientists otherwise hindered from studying RNA-transcription factor 
interactions.
MATERIALS
Cells
A375 cells (ATCC, cat. # CRL-1619, Manassas, VA), or appropriate cell line.
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Reagents
Plasmid generation
• Ampicillin (Sigma-Aldrich, cat. # A5354, Dorset, UK)
• LB Broth, Miller (ThermoFisher Scientific, cat. # BP1426-500, Waltham, MA)
• pcDNA3.1 (−) + FLAG-NLS-MS2-eGFP (Addgene, plasmid ID 86827, 
Cambridge, MA)
• Plasmid maxi kit (QIAGEN, cat. # 12162, Hilden, Germany)
Cell culture and manipulation
• 100 mm Tissue Culture dishes (ThermoFisher Scientific, cat. # 08772E, 
Waltham, MA)
• 500 ml disposable vacuum storage unit, 0.2 μM pore, PES membrane 
(ThermoFisher Scientific, cat. # 09-761-107, Waltham, MA)
• Cell scraper, 1.8 cm blade, 25 cm handle (Medsupply Partners, cat. # TL-
TR9000, Atlanta, GA)
• DMEM, high glucose, with pyruvate (ThermoFisher Scientific, cat. # 11995065, 
Waltham, MA)
• Fetal bovine serum (FBS) (ThermoFisher Scientific, cat. # 10437028, Waltham, 
MA)
• Lipofectamine 2000 Transfection Reagent (ThermoFisher Scientific, cat. # 
11668027, Waltham, MA)
• PBS (phosphate buffered saline), 1 ×, pH ~7.4 (ThermoFisher Scientific, cat. # 
MT21040CV, Waltham, MA)
Immunoprecipitation
• cOmplete, Mini, EDTA-free Protease Inhibitor Cocktail (Sigma, cat. # 
11836170001, St. Louis, MO)
• Dynabeads Prote in G (ThermoFisher Scientific, cat. # 10003D, Waltham, MA)
• FLAG peptide (Sigma, cat. # F3290, St. Louis, MO)
• Low binding 1.7 ml microcentrifuge tubes, polypropylene (Westnet, cat. # 3207, 
Canton, MA)
• Monoclonal ANTI-FLAG M2 antibody (Sigma, cat. # F1804, St. Louis, MO)
• Normal rabbit IgG (Santa Cruz Biotechnology, cat. # sc-2027, Dallas, TX)
• Phenylmethanesulfonyl fluoride (PMSF) solution (Sigma, cat. # 93482, St. 
Louis, MO)
• RNaseOUT Recombinant Ribonuclease Inhibitor (ThermoFisher Scientific, cat. 
# 10777019, Waltham, MA)
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• TF Activation Profiling Plate Array(s) (Signosis, Inc., cat. # FA-1001 – FA-1011, 
Santa Clara, CA)
• Tris HCl, molecular biology grade (ThermoFisher Scientific, cat. # BP153-500, 
Waltham, MA)
• Triton X-100, molecular biology grade (ThermoFisher Scientific, cat. # 
AC327371000, Waltham, MA)
Protein and RNA analysis
• 10 × Tris/Glycine/SDS Running Buffer (Bio-Rad, cat. # 1610732, Hercules, CA)
• 2 × Laemmli Sample Buffer (Bio-Rad, cat. # 1610737, Hercules, CA)
• Any kD Mini-PROTEAN TGX Precast Protein Gels, 10-well (Bio-Rad, cat. # 
4569033, Hercules, CA)
• iScript cDNA synthesis kit (Bio-Rad, cat. # 1708891, Hercules, CA)
• Precision Plus Protein Kaleidoscope Prestained Protein Standards (Bio-Rad, cat. 
# 1610375, Hercules, CA)
• RNeasy Micro Kit (QIAGEN, cat. # 74004, Hilden, Germany)
• SsoAdvanced Universal SYBR Green Supermix (Bio-Rad, cat. # 1725270, 
Hercules, CA)
Recipes
• 5 mg/ml FLAG stock solution in 1 × PBS
• Lysis buffer: 20 mM Tris HCl pH 7.4, 10 mM NaCl, 2 mM EDTA. Immediately 
prior to use, add detergent, and protease and RNase inhibitors as follows: 0.5% 
Triton X-100, 40 U/ml RNaseOUT, 1 mM PMSF, Roche protease inhibitor 
cocktail (–EDTA).
• Wash Buffer: 50 mM Tris pH 7.4, 200 mM NaCl. Immediately prior to use, add 
0.05% Triton X-100.
Equipment
• −20°C freezer
• −80°C freezer (optional)
• Bio-Rad CFX Connect machine and Bio-Rad CFX Manager 3.1 software (or any 
qPCR instrument and software)
• CO2 cell incubator
• DeNovix DS-11 (DeNovix, Wilmington, DE) or similar spectrophotometer
• Magnetic stand for 1.5 ml tubes
• Microplate reader with a 96-well microplate tray and associated software
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• Refrigerated centrifuge
• Shaking 37°C incubator for bacterial culture
• Vertical Electrophoresis Cell for Protein Gels (such as Mini-PROTEAN Tetra 
Cell, Bio-Rad, cat. # 1658005, Hercules, CA)
PROCEDURE
This protocol was optimized for the adherent A375 melanoma cell line. Expression, lysis 
and elution conditions may need to be optimized for each cell line, and steps requiring 
optimization are highlighted throughout this protocol and shown schematically in Figure 1. 
MS2-based IP of the RNA should be verified before completing the RATA protocol for an 
RNA of interest. To verify IP, complete the protocol through the washes at step 6.6.2, and 
split the eluate for western blot analysis of MS2 IP, and RT-qPCR analysis of RNA-IP. For 
all RNA isolations, lysate or eluate can be added directly to TRIzol®/TRIzol® LS or 
QIAGEN’s buffer RLT, and RNA isolation should be completed according to manufacturer’s 
instructions.
Plasmid generation
1 Design MS2-tagged and control expression vectors for RNA of interest
1.1 Clone your RNA of interest into an appropriate mammalian expression 
vector (such as pcDNA3.1, Invitrogen) and confirm expression in your 
cell line of choice via RT-qPCR. This will serve as the untagged 
control vector.
1.2 Insert 12 copies of the MS2 stem-loop RNA sequence at the 5′ or 3′ 
end of your RNA in the control vector. The MS2 stem-loop sequences 
may be cloned and inserted from preexisting vectors, such as Addgene 
plasmid # 27119 [8]. If possible, confirm that the insertion of the MS2 
stem-loop sequences do not interfere with normal functionality of the 
RNA. For example, differential gene expression or phenotypic changes 
may be quantified following transfection of either the untagged or 
tagged RNA.
CAUTION: Many lncRNA annotations include an AT-rich 
transcription termination sequence. Inclusion of this sequence 
upstream of the MS2 stem-loops may prematurely terminate 
transcription and exclude the MS2 stem-loop tag from the transcript. 
The RNA sequence of interest should be examined and, if present, the 
transcription termination sequence should be excluded from the MS2 
expression vector. To ensure similar expression levels between the 
tagged and untagged transcripts, we recommend cloning the same 
sequence for expression of both the control and MS2-tagged RNA.
NOTE: As with any screening methodology, the possibility of false 
positive hits should be considered. In RATA, false positive signals may 
result from non-specific interactions of transcription factors with the 
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MS2 stem-loops. To account for this possibility, we recommend 
performing a control RATA experiment using cells transfected with the 
MS2 fusion expression plasmid and either an empty or MS2 stem-loop 
expression plasmid, both lacking the RNA of interest. This will 
identify any transcription factor signals resulting from non-specific 
interactions with the MS2 stem-loop RNA tag. False positive signals 
may be reduced by optimizing the RATA protocol (for example, 
decreasing the amount of plasmid used for cell transfection). 
Additionally, signals from the control RATA experiment may be 
subtracted from RATA results using MS2 stem-loop expressing 
plasmid containing the RNA of interest.
2 Prepare plasmids
2.1 Culture E. coli containing RNA or MS2 expression plasmids overnight 
in a shaking incubator at 37°C in LB with ampicillin (100 μg/ml) or 
correct antibiotic for selection.
2.2 Purify plasmids using QIAGEN’s plasmid maxi kit according to 
manufacturer’s instructions.
2.3 Measure DNA concentration and purity using DeNovix.
Preparation of mammalian cell extract
All reagents and materials used during tissue culture manipulation should be used in a sterile 
tissue culture hood equipped with ultra-violet light for decontamination. Nuclear localization 
of the MS2 protein should be confirmed for each new cell line via fractionation and western 
blot analysis, or via microscopy.
3 Transfect mammalian cells
3.1 Seed cells at ~40% confluency (cell number depends on cell type) in 
10 cm dishes in appropriate media (such as DMEM + 10% FBS).
3.2 Incubate cells at 37°C in a humidified incubator, 5% (v/v) CO2, for at 
least 8 h, until cells reach ~70%–80% confluency.
3.3 Change cell medium.
3.4 Transiently co-transfect cells using Lipofectamine 2000 according to 
manufacturer’s protocol, with the FLAG-NLS-MS2-eGFP plasmid, 
and the lncRNA expression plasmid (either MS2-tagged or an 
untagged control).
TIP: (optimization): Transfection conditions may need to be 
optimized for each cell line. Cells should be transfected with varying 
amounts of each plasmid, grown for 24–72 h, and expression of the 
RNA and FLAG-NLS-MS2-eGFP fusion protein should be quantified 
by RT-qPCR and western blot analysis, respectively. Optimal 
expression in the melanoma cell line A375 was observed using 10 μg 
Schmidt et al. Page 7
J Biol Methods. Author manuscript; available in PMC 2017 December 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
of the FLAG-NLS-MS2-eGFP plasmid and 8 μg of the lncRNA 
expression plasmids, 48 h. post-transfection.
3.5 Grow cells for 24–74 h.
4 Harvest cells
4.1 Remove media, and rinse cells in 3 ml 1 × PBS.
4.2 Detach cells by scraping into 5 ml of ice cold 1 × PBS.
NOTE: Cells may also be detached by trypsinization (incubate cells 
with ~3 ml of trypsin for ~5 min or until cells detach, transfer to 15 ml 
conical tube with ~7 ml of media, and collect cells by centrifugation at 
300 × g for 3 min) followed by an additional rinse in 5 ml of 1 × PBS.
4.3 Collect cells by spinning at 300 × g for 3 min, remove PBS.
TIP: Cells may also be snap-frozen (using liquid nitrogen or crushed 
dry ice) and stored at −80°C if not proceeding directly to cell lysis and 
IP.
Cell lysis and IP
To prevent loss of RNA, we recommend the use of low-adhesion/retention tubes and pipette 
tips for all steps of IP.
5 Lyse cells
5.1 Add 500 μl of cold lysis buffer. Pipette up and down to resuspend 
cells, and transfer to a 1.5 ml tube.
5.2 Rotate at 4°C for 10 min.
5.3 Add NaCl to a final concentration of 150 mM (15 μl of 5 M NaCl into 
500 μl).
TIP: (optimization): These lysis conditions do not completely disrupt 
the nucleus, but rather allow for ‘leaking’ of nuclear proteins. NaCl 
concentrations may need to be optimized for each cell line. To 
optimize NaCl concentration, divide equal volumes of cell suspensions 
into 1.5 ml tubes, add varying amounts of NaCl to each tube that 
covers a range between 150 mM to 300 mM final NaCl concentrations, 
and complete protein lysis. Western blot analysis and probing with an 
anti-FLAG antibody will confirm the concentration of NaCl required 
for maximal isolation of the FLAG-NLS-MS2-eGFP protein.
5.4 Incubate on ice for 10 min, with occasional and gentle swirling.
5.5 Centrifuge at 17000 × g at 4°C for 10 min, and transfer supernatant to 
new tube.
5.6 Measure protein concentration on DeNovix.
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5.7 Save 2 × 25 μl input samples: one for RNA and one for protein 
analysis. For protein analysis, add 25 μl of 2 × Laemmli buffer and 
boil for 5 min at 95 °C. For RNA analysis, add 350 μl QIAGEN buffer 
RLT and complete RNA isolation according to manufacturer’s 
protocol.
NOTE: RNA may also be isolated using TRIzol® LS Reagent 
(Invitrogen, cat. # 10296010, Carlsburg, CA) following manufacturer’s 
instructions. The use of an RNA carrier (such as glycogen) may be 
required for enhancement of RNA recovery from low yield inputs.
6 Perform immunoprecipitation
6.1 Add 2.5 μg ANTI-FLAG® M2 antibody (Sigma) to cell lysate.
TIP: (optimization): If optimizing MS2 protein IP, split cell lysate, and 
add ANTI-FLAG® M2 antibody (Sigma) to one half, and matched IgG 
control antibody to the other half. This will allow optimization of 
MS2-based IP of the RNA of interest compared to the IgG non-
specific control. The amount of antibody may need to be adjusted 
depending on the expression level of the fusion protein in your cell line 
of interest. Once RNA-IP is optimized, RATA should be completed 
from anti-FLAG IPs of lysates expressing either the tagged or 
untagged RNA.
6.2 Rotate for 2 h at 4°C.
TIP: IP may also be performed overnight.
6.3 Prepare beads
6.3.1 Pipette 2 × 25 μl protein-G beads (50% slurry) into two 1.5 
ml low-adhesion tubes, add 500 μl of PBS, place tubes on 
magnet and remove supernatant.
6.3.2 Wash 1 time with 500 μl 1 × PBS.
6.3.3 Wash 1 time in 100 μl salt-supplemented cell lysis buffer.
6.4 Add cell lysate to prepared beads.
6.5 Rotate for 1 h at 4°C.
6.6 Wash beads
6.6.1 Remove supernatant.
TIP: (optimization): If optimizing protein IP conditions (see 
step 6.1), save flow through samples (~25 μl) for protein 
analysis.
6.6.2 Wash 5 times in 500 μl with MS2 low salt wash buffer.
TIP: (optimization): If optimizing IP conditions, add 25 μl 2 
× Laemmli buffer directly to beads following washed and 
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boil for 5 min at 95°C. Remove samples from beads and split 
for protein and RNA analysis. For RNA analysis, add 350 μl 
of QIAGEN buffer RLT and complete RNA isolation 
following manufacturer’s instruction. Once IP has been 
confirmed, proceed directly to elution.
7 Elute RNA and associated proteins
7.1 Prepare 100 μg/ml FLAG peptide in wash buffer by diluting 5 μl of 
FLAG stock solution (5 mg/ml in 1x PBS) into 250 μl wash buffer.
7.2 Add 25 μl of FLAG peptide solution to lysate.
7.3 Rotate for 30 min at 4°C.
7.4 Remove and save eluate.
7.5 Repeat steps 7.2 through 7.4 for a total of 2–3 elutions.
TIP: (optimization): If performing the elution for the first time, RT-
qPCR and western blot analysis should be performed to determine 
when optimal elution occurs. To determine elution efficiency, add 25 
μl of 2× Laemmli buffer directly to beads and boil for 5 min at 95°C. 
Remove samples from beads and split for protein and RNA analysis. 
The fraction containing the highest amount of RNA should be used for 
subsequent analysis in the TF Activation Profiling Plate Array. 
Alternatively, 2–3 elutions may be combined.
TIP: Elution may be snap-frozen (using liquid nitrogen or crushed dry 
ice) and stored at −80°C if not proceeding directly to TF activation 
profiling plate array.
8 Perform TF Activation Profiling Plate Array
8.1 Mix the following components in a low-adhesion 1.5 ml tube: 15 μl TF 
binding buffer (from kit), 3 μl TF Probe mix (from kit) and 12 μl 
Eluate (from step 7.5).
8.2 Follow manufacturer’s instructions to complete the transcription factor 
array.
CRITICAL STEP: The transcription factor activation array must be 
completed for both the tagged RNA-IP and the untagged RNA-IP 
negative control simultaneously in order to allow determine IP-specific 
transcription factor enrichments. The use of the untagged RNA control 
will account for any changes in expression (and therefore background 
signal) of any transcription factors affected by expression of the RNA.
8.3 Following completion of the protocol and quantification of the signal 
from each well on a microplate reader, analyze the data as follows (and 
as exemplified in Table 1):
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8.3.1 Normalize raw values by calculating the ratio of each 
transcription factor specific signal over the signal of a non-
specific probe (i.e. the signal corresponding to a transcription 
factor that is not bound by the RNA of interest). 
Transcription factor II D (TFIID) can be used in most cases.
8.3.2 Calculate individual transcription factor enrichment by 
taking the ratio of the normalized signal of the specific 
(tagged) RNA-IP compared to the normalized signal of the 
control (untagged) RNA-IP.
NOTE: To account for fluctuations in transcription factor 
levels between samples, we recommend repeating the assay 
for a total of 2–3 biological replicates to confirm specific 
signals.
ANTICIPATED RESULTS
The protocol proved here offers low-cost, highly-sensitive identification of transcription 
factors associated with an RNA of interest. Our method uses a slightly modified MS2-based 
IP, which has successfully been used to purify RNAs, including lncRNAs [9,10]. We have 
designed a plasmid expressing an exclusively nuclear version of FLAG-tagged MS2-eGFP 
fusion protein (Fig. 2). While fractionation and western blot analysis of A375 cells 
transfected with this plasmid confirms nuclear localization of the FLAG-NLS-MS2-eGFP 
fusion protein (Fig. 3), nuclear localization of the fusion protein should be confirmed for 
each new cell line prior to RATA. As an alternative to cellular fractionation, localization may 
be verified through microscopy-based visualization of the eGFP tag.
Recently, we used RATA to identify transcription factors associated with the lncRNA 
SLNCR1 (LINC00673) [6]. As shown in Figure 3, lysis conditions used in this protocol 
efficiently recover the nuclear fusion protein, and the associated MS2-tagged SLNCR1 RNA 
is routinely enriched ~100-fold over an untagged control (Fig. 4A and Fig. 4B). As opposed 
to recovery of bound proteins and RNAs through boiling in 2 × Laemmli buffer (Fig. 4A and 
4B), elution using FLAG peptide recovers slightly lower amounts of protein and RNA, 
usually between 5- and 40-fold enrichment of the tagged RNA (Fig. 5A and 5B). Despite 
this lower recovery, RATA is sensitive enough to detect transcription factors present in eluate 
from FLAG peptide elution (Table 1) even when the transcription factor (in this example, the 
androgen receptor (AR)) is not detectable via western blot analysis of the MS2-tagged 
SLNCR1 immunoprecipitate (Fig. 4A). In addition to being very sensitive, enrichments 
detected via RATA are highly-reproducible between biological replicates. For example, 
RATA of SLNCR1 shows reproducible enrichment of Brn3a (25-fold in replicate 1, and 12-
fold in replicate 2), AR (10-fold in replicate 1, and 8-fold in replicate 2), and PAX5 (8-fold 
in replicate 1, and 11-fold in replicate 2) (Table 1 and data not shown). Thus, because levels 
of transcription factors may naturally fluctuate between samples, IP-specific signals may be 
confirmed through 2–3 biological replicates of RATA.
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Because our methodology requires overexpression of the tagged RNA of interest, there are 
important potential caveats to consider when using this approach. First, inclusion of an RNA 
tag may affect secondary structure of the RNA, and therefore may also affect interactions 
with partner proteins. If possible, phenotypic or gene expression changes should be 
quantified following overexpression of either the untagged or tagged RNA to determine if 
the tag interferes with normal functionality of the RNA (Step 1.2.1). Ideal placement of the 
RNA tag may need to be determined empirically. Second, overexpression of RNA may 
increase/induce non-specific binding with proteins that do not interact with the RNA under 
physiological conditions. Thus, candidate RNA-transcription factor interactions identified 
through RATA should be validated through orthogonal assays. For example, RNA 
immunoprecipitation (RIP) assays, in which a protein of interest is immunoprecipitated and 
associated RNAs are identified through RT-qPCR, may be used to confirm if a candidate 
transcription factor interactor identified through RATA maintains its interaction with 
endogenous RNAs [13]. Indeed, RIP assays confirmed the two top SLNCR1 interactors 
(Brn3a and AR) [6].
While RATA is limited to the identification of transcription factors included in the arrays, 
there are multiple versions of commercially available transcription factor activation arrays 
compatible with this technique. Signosis offers 12 different arrays, each including various 
combinations of over 150 unique transcription factors. Panomics offers 5 different 
transcription factor activation arrays (TranSignal™ Protein/DNA Array Systems), with their 
largest array (Combo Array) able to quantify 345 transcription factors in a single assay. 
Collectively, the Panomics and Signosis Arrays cover over 400 unique transcription factor in 
varying combinations. Importantly, these transcription factors represent the most 
biologically relevant and well-characterized transcription factors, covering approximately 
25% of the 1672 currently identified human transcription factors [14]. Additionally, because 
the TranSignal™ Arrays rely on membrane-based chemiluminescent detection, with DNA 
probes spotted on a membrane rather than a 96-well plate, these arrays may be ideal for 
scientists who do not have access to a plate reader. For scientists with access to a Luminex 
machine, Panomics also offers two Luminex® based assays capable of quantifying 40 
transcription factors in up to 96 samples (such as controls, technical- and/or biological-
replicates) in a single plate. The wide variety of transcription factor arrays available enables 
great flexibility in assay design. The selection of a transcription factor array depends on the 
RNA being studied and the type of information desired. For example, if a scientist is 
interested in testing the hypothesis that a lncRNA binds to transcription factors, Signosis’ 
Array I or II, which contain 48 or 96 of the most well-studied transcription factor, 
respectively (many of which have been shown to bind to lncRNAs), may be suitable. 
Alternatively, if the lncRNA in question is expressed exclusively in cancer and implicated in 
tumorigenesis, Signosis’ Cancer Stem Cell Array (containing 4 sets of 23 transcription 
factor specific probes) may be appropriate. For a more comprehensive analysis of associated 
transcription factors, scientists may choose to screen multiple arrays, or use the 345 probe 
Panomics Combo Array. It may also be helpful to consider which transcription factors are 
expressed in the cell line being tested; however, the arrays are very sensitive and are capable 
of detecting transcription factors even when they are not detected via western blotting.
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This report details a novel protocol for the efficient and low cost identification of 
transcription factors associated with an RNA of interest, including lncRNAs. We have 
designed an exclusively nuclear MS2 fusion protein and optimized conditions to enable 
highly efficient isolation of ribonucleoprotein complexes. This easily implemented protocol 
will enable scientists from a range of fields to more efficiently and comprehensively 
investigate the role that RNAs play in modulating transcription factor activity and regulating 
gene expression.
TROUBLESHOOTING
Potential problems and troubleshooting suggestions are listed in Table 2.
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Figure 1. Flow diagram of RATA protocol
Optional optimization steps are denoted on the right with the corresponding step in the 
RATA protocol highlighted.
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Figure 2. Schematic representation of the pcDNA3.1 (−) + FLAG-NLS-MS2-eGFP vector
The MS2 fusion protein is expressed from the pcDNA3.1 (−) constitutive CMV promoter. 
NLS = SV40 NLS sequence, 3C = human rhinovirus 3C protease cleavage site. Selected 
restriction enzymes sites within the inserted sequence are highlighted.
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Figure 3. Western blot analysis confirms nuclear localization of MS2 fusion protein
A375 cells transfected with the pcDNA3.1 (−) + FLAG-NLS-MS2-eGFP vector were 
fractionated with the ThermoFisher Scientific NE-PER Nuclear and Cytoplasmic Extraction 
Kit, according to the manufacturer’s instructions. Cytoplasmic (C) and nuclear (N) fractions 
were subjected to western blot analysis. The blot was immunoblotted (IB) with monoclonal 
ANTI-FLAG M2 antibody (Sigma), α-Hsp90 4F10 antibody (Santa Cruz), and α-GAPDH 
14C10 antibody (Cell Signaling Technology).
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Figure 4. Western blot analysis fails to identify AR, a known SLNCR1 interactor, after MS2-
based RNA-IP
(A) A375 cells were transfected with 10 μg of the FLAG-NLS-MS2-eGFP expressing 
plasmid and 8 μg of an untagged (control) or 12 × MS2 binding site 3′ tagged SLNCR1 
expression vector. FLAG-tagged MS2 was immunoprecipitated from A375 using an anti-
FLAG antibody, and total protein input or bound proteins was subjected to western blot 
analysis. The blot was probed with 1:200 α-androgen receptor (AR) N-20 (Santa Cruz 
Biotechnology), 1:5000 ANTI-FLAG M2 (Sigma) and 1:5000 α-GAPDH (Cell Signaling). 
The FLAG-NLS-MS2-eGFP protein has a predicted molecular weight of approximately 45 
kDa, and is detectable below the IgG heavy chain located at approximately 50 kDa. (B) 
Relative enrichment of the indicated transcripts as measured by RT-qPCR compared to RNA 
enriched from cells expressing SLNCR1 without MS2 stem-loops. Total proteins and RNAs 
were released by incubating in Laemmli buffer at 95°C for 5 min.
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Figure 5. MS2-based IP and FLAG peptide elution significantly enriches the lncRNASLNCR1
(A) A375 cells were transfected with 10 μg of the FLAG-NLS-MS2-eGFP expressing 
plasmid and 8 μg of a 12 × MS2 binding site 3′ tagged SLNCR1 expression vector. FLAG-
tagged MS2 was immunoprecipitated from A375 using an α-FLAG antibody, and bound 
proteins and RNAs were eluted by incubation with FLAG peptide for 30 min at 4°C. E1 
refers to the first elution, E2 refers to a second elution from the same IP. Total protein input 
or eluted proteins were subjected to western blot analysis, and the blot was probed with 
1:5000 ANTI-FLAG M2 (Sigma) and 1:5000 α-GAPDH (Cell Signaling). (B) Relative 
enrichment of the indicated transcripts from E2 as measured by RT-qPCR compared to RNA 
enriched from cells expressing SLNCR1 without MS2 stem-loops.
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Table 1
Example data obtained from RATA using the lncRNA SLNCR1.
Transcription factor Values Normalized values Fold enrichment
Control SLNCR1 (no MS2-loops) Brn-3 17421 0.18
AR 26840 0.27
Pax-5 178321 1.82
GR/PR 53194 0.54
NFAT 110426 1.12
SMAD 276121 2.81
MEF2 94463 0.96
GATA 98180 1.00
MS2-tagged SLNCR1 Brn-3 122792 4.48 25.27
AR 77925 2.85 10.41
Pax-5 407732 14.89 8.20
GR/PR 15177 0.55 1.02
NFAT 25774 0.94 0.84
SMAD 90559 3.31 1.18
MEF2 19599 0.72 0.74
GATA 27381 1.00 1
RATA was performed with A375 cell lysates transfected with pcDNA3.1 (−) + FLAG-NLS-MS2-eGFP and a vector expressing either the untagged 
or MS2-tagged SLNCR1. Eluate was subjected to the Signosis, Inc.’s TF Activation Profiling Plate Array I, and transcription factor names 
correspond to names in the array. Shown are signals for selected transcription factors selected from a signal, representative assay. Raw fluorescence 
values are shown in column 3, and normalized values are shown in column 4 (calculated as the ratio of the transcription factor specific signal over 
the GATA signal). Fold enrichment is calculated as the ratio of the normalized signal of MS2-tagged IP versus the normalized signal of the 
untagged control IP.
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Table 2
Troubleshooting table.
Step Problem Cause Suggestion
1.1 RNA is not expressed • Incompatible promoter in plasmid • Find an expression plasmid 
compatible with your cells
3.4 No expression of fusion 
MS2 protein, or RNA
• Inefficient transfection • Check purity of plasmid DNA, and 
ethanol precipitate DNA if necessary
• Optimize DNA transfection conditions 
for cells
6.6 Failure to IP MS2 protein • MS2 protein is not being released 
from nucleus during lysis
• Insufficient antibody and/or 
dynabeads
• Test multiple NaCl concentrations to 
find optimal concentration for release 
of nuclear MS2 protein
• Increase the amount of FLAG 
antibody and/or dynabeads
6.6 No enrichment of RNA in 
IP
• MS2 stem-loop sequences are not 
included in mature transcript
• MS2 stem-loop sequences are 
blocked from binding to MS2 
protein
• Examine RNA sequence and remove 
AT-rich transcription termination 
sequence upstream of MS2 sequences 
(if 3′ tagged)
• Move RNA tag to the other end of the 
transcript
6.6 No detectable RNA • Presence of RNase(s) in one or 
more buffer causing RNA 
degradation
• Use only nuclease-free reagents and 
buffers throughout procedure
• Filter buffers through a 0.2 μM filter 
to remove RNase(s)
6.6 RNA is only detectable 
from input samples
• RNA concentration in IPs is too 
low for efficient isolation
• If using a Trizol based RNA 
extraction, include an RNA carrier 
(such as glycogen) to increase RNA 
recovery
7.5 Failure to elute MS2 
protein
• Degradation of FLAG peptide • Remake FLAG peptide dilution in 
protease-free PBS
• Aliquot FLAG stock solution to avoid 
multiple freeze-thaws
8 Failure to enrich 
transcription factors
• Overwashing is stripping 
transcription factors from 
ribonucleoprotein complexes
• Reduce the number of washes, or 
reduce the level of detergent in wash 
buffer
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